Browse the complete Report on Antipodean Pharmaceuticals, Inc.-Detailed Product Pipeline
Browse All Life Science Analytics Research Reports
Antipodean Pharmaceuticals, Inc.-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Scope of the reports

Each Life Science Analytics’ Pipeline Report provides the user with real detail on a company’s pipeline.

In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company’s product pipeline and disease hub classification.

Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company’s deals and alliances and recent corporate news including key milestones.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

Table Of Contents
Business Summary
Financials
Product Glance
Products by Phase of Development
Products by Disease Hub Classification
Products by Indication

Upcoming Milestones
Product Summary
Product Details
Recent Updates

About Us:
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004

http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Original Source : Antipodean Market
Buy Now: Market Research Reports

Browse the complete Report on Adnexus Therapeutics, Inc.-Detailed Product Pipeline

Browse All Life Science Analytics Research Reports at Life Science Analytics

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

• How proteomics is being used to identify biomarkers for new diagnostics in infectious diseases
• How proteomics is being used to identify novel targets for drug discovery and vaccine development in infectious diseases
• The impact of genomics on the search for novel targets for infectious disease drug discovery
• Novel natural sources for lead generation in infectious diseases
• Lead optimization techniques relevant to infectious diseases
• How the application of nanobiotechnology is impacting on drug discovery and drug delivery in infectious diseases

• Gain awareness of the most significant areas of unmet need for anti-infective drug development.
• Build knowledge of the most promising diagnostics research – ripe for commercialization – for MRSA and community-acquired infections, bacterial meningitis, periodontal disease, and innovative ways for predicting outcome in hepatitis infections.
• Discover how proteomics and genomics are making an increasing impact on drug development programs, and how important infectious agents can be tackled by drug and vaccine approaches.
• Identify the new opportunities for small and large biotechnology based companies to undertake vaccine development based on proteomic and genomic studies

• More accurate and rapid diagnostics will remain a pressing need combating prion diseases, sexually transmitted diseases, HIV, hospital-acquired infections and bioterrorism threats.
• Diagnostics is a big area that is ripe for more commercial development, particularly for diagnostic kits that are fast and simple to operates by unskilled personnel, making them amenable to the point-of-care use.
• Personalized medicine will remain a priority; drug treatments need to be more tailored and efficient with fewer side effects, less frequent dosing, and faster action..
• Using genomics to monitor and carry out surveillance of infectious disease will become more important and more necessary, so that new outbreaks, spread of disease, and danger of pandemics can be better monitored and predicted by global warning systems.
• The need to identify, monitor, and respond to bioterrorism will continue to drive research into lethal viral infections such as small pox and ebola, and bacterial diseases such as anthrax and plague.

• Drug development, vaccine development, and novel approaches to therapeutics are needed urgently for bacterial, viral, fungal, and prion diseases, which cause high morbidity and mortality in both the developing and the developed world.
• To date, there has been an intensive research effort to use proteomics to detect, identify, characterize, and validate biomarkers and protein signatures in diagnostics for many different infectious diseases but validation and commercialization has so far proved relatively elusive.
• Drug resistance, emerging infections and the threat of bioterrorism make the understanding of virulence factors and disease pathogenesis essential to form a springboard from which to launch drug discovery programs.
• Genomics is being applied to drug discovery across the spectrum of infectious diseases, whether they are caused by bacteria, viruses, fungi, parasites, or prions. Genomic data can be used in public health surveillance and monitoring of infectious diseases, particularly when there is a threat of a pandemic or bioterrorist attack.
• Novel sources of lead compounds to screen against newly discovered targets are much needed; natural sources have already provided the starting point for several successful anti-infectives, and many sources remain to be explored.

• Which areas of drug development in infectious disease could have the greatest impact?
• How can the relatively new technology of proteomics be used to develop leads for drug development?
• How are proteomic techniques being used in the design and production of modern diagnostic tools for infectious diseases?
• How are genomic technologies changing the way lead compounds are generated and providing ideas for innovative targeted drugs?
• In which bacteria, viral, fungal and prion diseases are fundamental research efforts showing the most potential for identifying compounds suitable for drug development?

Browse the complete Report on: Acorda Therapeutics Inc-Detailed Product Pipeline

Browse All Verdict Research Reports at Life Science Analytics

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

• Products by Phase of Development
• Products by Disease Hub Classification
• Products by Indication

• Product Revenue All Values in US Dollar (in millions)

• Company Announcements
• Regulatory